Idiopathic inflammatory myopathies

IE Lundberg, M Fujimoto, J Vencovsky… - Nature Reviews …, 2021 - nature.com
Idiopathic inflammatory myopathies (IIM), also known as myositis, are a heterogeneous
group of autoimmune disorders with varying clinical manifestations, treatment responses …

Interferon target-gene expression and epigenomic signatures in health and disease

FJ Barrat, MK Crow, LB Ivashkiv - Nature immunology, 2019 - nature.com
Multiple type I interferons and interferon-γ (IFN-γ) are expressed under physiological
conditions and are increased by stress and infections, and in autoinflammatory and …

JAK inhibitors for the treatment of autoimmune and inflammatory diseases

Y Jamilloux, T El Jammal, L Vuitton… - Autoimmunity …, 2019 - Elsevier
Cytokines play a central role in the pathophysiology of autoimmune and inflammatory
diseases. Several cytokines signal through the JAK-STAT pathway, which is now recognized …

Study of tofacitinib in refractory dermatomyositis: an open‐label pilot study of ten patients

JJ Paik, L Casciola‐Rosen, JY Shin… - Arthritis & …, 2021 - Wiley Online Library
Objective This open‐label 12‐week study was conducted to evaluate the efficacy and safety
of tofacitinib, a JAK inhibitor, in treatment‐refractory active dermatomyositis (DM). Methods …

239th ENMC international workshop: classification of dermatomyositis, Amsterdam, the Netherlands, 14–16 December 2018

AL Mammen, Y Allenbach, W Stenzel… - Neuromuscular …, 2020 - Elsevier
Idiopathic inflammatory myopathies (IIM) are a heterogenous family of diseases that can
affect the muscles, skin, lungs, and joints. There have been prior attempts to classify IIMs …

Use of JAK inhibitors in dermatomyositis: a systematic literature review

JJ Paik, G Lubin, A Gromatzky… - Clinical and …, 2022 - pmc.ncbi.nlm.nih.gov
Dermatomyositis (DM) is an idiopathic inflammatory myopathy that commonly manifests with
proximal muscle weakness and is associated with extramuscular pathology including …

British Society for Rheumatology guideline on management of paediatric, adolescent and adult patients with idiopathic inflammatory myopathy

AGS Oldroyd, JB Lilleker, T Amin, O Aragon… - …, 2022 - academic.oup.com
Background Idiopathic inflammatory myopathy (IIM) is a multi-system autoimmune condition
characterised by muscle inflammation (myositis), interstitial lung disease (ILD), and skin …

Type I interferons in the pathogenesis and treatment of autoimmune diseases

J Jiang, M Zhao, C Chang, H Wu, Q Lu - Clinical reviews in allergy & …, 2020 - Springer
Abstract Type I interferons (IFN-Is) are a very important group of cytokines that are produced
by innate immune cells but also act on adaptive immune cells. IFN-Is possess antiviral …

[HTML][HTML] Where are we moving in the classification of idiopathic inflammatory myopathies?

J Tanboon, A Uruha, W Stenzel… - Current opinion in …, 2020 - journals.lww.com
Where are we moving in the classification of idiopathic infl... : Current Opinion in Neurology
Where are we moving in the classification of idiopathic inflammatory myopathies? : Current …

Antisynthetase syndrome–much more than just a myopathy

AH Opinc, JS Makowska - Seminars in Arthritis and Rheumatism, 2021 - Elsevier
The aim of the study was to summarize current knowledge on antisynthetase syndrome
(ASS), including its epidemiology, pathogenesis, proposed so far diagnostic criteria …